Emergent BioSolutions Inc. (EBS)

NYSE: EBS · IEX Real-Time Price · USD

2.180

-0.110 (-4.80%)

At close: Apr 24, 2024, 4:00 PM

2.250

+0.070 (3.21%)

After-hours: Apr 24, 2024, 7:19 PM EDT

Emergent BioSolutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Cash & Equivalents	111.7	642.6	576.3	621.5	168	112.4	179.3	271.51	308.3	280.5	Upgrade
Cash & Cash Equivalents	111.7	642.6	576.3	621.5	168	112.4	179.3	271.51	308.3	280.5	Upgrade
Cash Growth	-82.62%	11.50%	-7.27%	269.94%	49.47%	-37.31%	-33.96%	-11.93%	9.91%	56.41%	Upgrade
Receivables	191	159.2	278.9	230.9	270.7	262.5	143.7	138.48	113.91	58.83	Upgrade
Inventory	328.9	350.7	344.5	307	222.5	205.8	142.8	74	60.89	65.67	Upgrade
Other Current Assets	47.9	57.9	70.2	36.5	25	40.1	19.6	26.23	54.31	27.17	Upgrade
Total Current Assets	679.5	1,210	1,270	1,196	686.2	620.8	485.4	510.22	537.41	432.18	Upgrade
Property, Plant & Equipment	382.8	817.6	800.1	644.1	542.3	510.2	407.2	376.45	327.81	313.98	Upgrade
Goodwill and Intangibles	566.6	947	829.5	929.8	979.5	1,021	168.7	74.87	81.76	110.93	Upgrade
Other Long-Term Assets	194.3	191.3	58.2	113.4	119.3	77.1	8.9	8.58	90.51	81.61	Upgrade
Total Long-Term Assets	1,144	1,956	1,688	1,687	1,641	1,609	584.8	459.89	500.07	506.52	Upgrade
Total Assets	1,823	3,166	2,958	2,883	2,327	2,229	1,070	970.11	1,037	938.69	Upgrade
Accounts Payable	112.2	103.5	128.9	136.1	94.8	80.7	41.8	34.65	37.97	40.93	Upgrade
Deferred Revenue	0	0	0	0	0	0	30.5	15.47	7.41	11.06	Upgrade
Current Debt	413.7	957.3	31.6	33.8	12.9	10.1	0	20	0	0	Upgrade
Other Current Liabilities	125.4	168.1	213.5	214.6	108.6	109.6	27.8	35.74	54.24	40.95	Upgrade
Total Current Liabilities	651.3	1,229	374	384.5	216.3	200.4	100.1	105.86	99.61	92.94	Upgrade
Long-Term Debt	446.5	448.5	809.4	841	798.4	784.5	13.5	248.09	246.89	251	Upgrade
Other Long-Term Liabilities	76.1	101.2	162.8	210.7	224.1	233.6	44.3	19.96	30.96	41.55	Upgrade
Total Long-Term Liabilities	522.6	549.7	972.2	1,052	1,023	1,018	57.8	268.05	277.86	292.55	Upgrade
Total Liabilities	1,174	1,779	1,346	1,436	1,239	1,219	157.9	373.91	377.47	385.49	Upgrade
Total Debt	860.2	1,406	841	874.8	811.3	794.6	13.5	268.09	246.89	251	Upgrade
Debt Growth	-38.81%	67.16%	-3.86%	7.83%	2.10%	5785.93%	-94.96%	8.59%	-1.64%	304.84%	Upgrade
Retained Earnings	-21.8	738.7	950.3	726.9	421.8	367.3	337.1	254.48	351.14	288.27	Upgrade
Comprehensive Income	-5.7	3.1	-16.1	-25.3	-9.9	-5.5	-3.7	-4.33	-2.71	-3.01	Upgrade
Shareholders' Equity	649.3	1,388	1,612	1,447	1,089	1,011	912.3	596.21	660.02	553.2	Upgrade
Net Cash / Debt	-748.5	-763.2	-264.7	-253.3	-643.3	-682.2	165.8	3.42	61.41	29.5	Upgrade
Net Cash / Debt Growth	-	-	-	-	-	-	4749.37%	-94.43%	108.18%	-74.86%	Upgrade
Net Cash Per Share	-14.62	-15.23	-4.89	-4.71	-12.28	-13.27	3.30	0.07	1.30	0.64	Upgrade
Working Capital	28.2	-18.5	895.9	811.4	469.9	420.4	385.3	404.36	437.8	339.24	Upgrade
Book Value Per Share	12.68	27.70	30.12	27.46	21.14	20.18	21.82	14.83	17.10	14.81	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).